LHC seeks record of hike in prices of medicines from DRAP
LAHORE: The Lahore High Court (LHC) on Wednesday directed the Drug Regulatory Authority of Pakistan (DRAP) to furnish the record pertaining to the recent hike in prices of medicines. A counsel on behalf of the DRAP informed the court that committees on the issue of drug price hike have been constituted.
Petitioner Advocate Azhar Siddique strongly objected to the DRAP counsel’s statement and said the committees were doing nothing. He contended that the prices of medicines were jacked up without any plausible reason and the lives of poor people had been made more miserable.
He said that rates of essential lifesaving medicines have been increased by up to 262 per cent by the DRAP in violation of the laws, which has added to the miseries of inflation-hit people. He requested the court to declare the increase illegal. Justice Sethi directed the DRAP to submit all record regarding medicine price hike till the next date of hearing.
-
OpenAI Launches ChatGPT Translate To Rival Google Translate -
Top AI Themes Poised To Shape 2026: Here’s How -
Meghan Markle Accused Of Stealing 'bookmark' Idea -
Leonardo DiCaprio Changes His Stance On THIS To Remain 'his Handsome Self' -
Girl Dies After Years Of Alleged Starvation By Mother In West Virginia -
Here’s How Many Under-16 Social Media Accounts Were Removed In Australia -
Drew Barrymore Gets Candid About The Words That Haunted Her Childhood -
Why Fans Fell For Scammers Impersonating Reese Witherspoon -
'Stranger Things' Star David Harbour Opens Up About Manic Episodes -
Elon Musk Predicts That Solar Power Can Supply The Global Demand For All Of Humanity’s Energy -
Keith Urban Takes Extreme Measures To Not 'air Dirty Laundry' Post-Nicole Kidman Divorce -
Louis Tomlinson Reveals Hidden Anxiety -
Defying Age At Milano Cortina Games: Canadian Skater Stellato-Dudeke Aims For Gold At 42 -
Study Finds Screen Time Does Not Harm Teenagers’ Mental Health -
'Dunesday': What Robert Downey Jr. And Timothee Chalamet Really Think -
UK Regulator Reaffirms Ongoing Investigation Into X Deepfake Probe